Past, present and future perspectives in nonalcoholic fatty liver disease

被引:358
|
作者
Sanyal, Arun J. [1 ]
机构
[1] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Sch Med, Richmond, VA 23284 USA
关键词
UNFOLDED PROTEIN RESPONSE; TOLL-LIKE RECEPTORS; LONG-TERM OUTCOMES; UNITED-STATES; VITAMIN-E; INSULIN-RESISTANCE; HEPATIC STEATOSIS; FIBROSIS STAGE; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY;
D O I
10.1038/s41575-019-0144-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) was first described as a distinct clinical entity four decades ago. However, the condition has become the centre of attention within hepatology owing to its high prevalence and growing contribution to the burden of end-stage liver disease in the general population. This Perspective provides an overview on the development of knowledge related to NAFLD with a focus on landmark findings that have influenced current paradigms and key knowledge gaps that need to be filled to make progress. Specifically, a timeline of scientific discovery of both basic disease mechanisms (with a focus on human data) and the evolution of knowledge about the clinical course of the disease is provided and related to current approaches to treat and eventually prevent NAFLD.
引用
收藏
页码:377 / 386
页数:10
相关论文
共 50 条
  • [11] Treatment of Fatty Liver Disease: The Present and the Future
    Ramanan, Sruthi Priyavadhana
    Mohamed, Mohamed Wael F.
    Aung, Su Sandi
    Sange, Ibrahim
    Hamid, Pousette
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [12] Perspectives on youth-onset nonalcoholic fatty liver disease
    Castillo-Leon, Eduardo
    Cioffi, Catherine E.
    Vos, Miriam B.
    [J]. ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (04)
  • [13] Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Younossi, Zobair M.
    Loomba, Rohit
    Rinella, Mary E.
    Bugianesi, Elisabetta
    Marchesini, Giulio
    Neuschwander-Tetri, Brent A.
    Serfaty, Lawrence
    Negro, Francesco
    Caldwell, Stephen H.
    Ratziu, Vlad
    Corey, Kathleen E.
    Friedman, Scott L.
    Abdelmalek, Manal F.
    Harrison, Stephen A.
    Sanyal, Arun J.
    Lavine, Joel E.
    Mathurin, Philippe
    Charlton, Michael R.
    Chalasani, Naga P.
    Anstee, Quentin M.
    Kowdley, Kris V.
    George, Jacob
    Goodman, Zachary D.
    Lindor, Keith
    [J]. HEPATOLOGY, 2018, 68 (01) : 361 - 371
  • [14] Liver transplantation for alcoholic liver disease: Past, present, and future
    Lucey, Michael R.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (02) : 190 - 192
  • [15] Nonalcoholic fatty liver disease - current status and future directions
    Demir, Muenevver
    Lang, Sonja
    Steffen, Hans-Michael
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2015, 16 (10) : 541 - 557
  • [16] MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease
    Kozaka, Kazuto
    Matsui, Osamu
    [J]. RADIOLOGY, 2023, 309 (01)
  • [17] What's Past Is Prologue: History of Nonalcoholic Fatty Liver Disease
    Targher, Giovanni
    [J]. METABOLITES, 2020, 10 (10) : 1 - 5
  • [18] Nonalcoholic fatty future disease
    Polyzos, Stergios A.
    Mantzoros, Christos S.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1007 - 1016
  • [19] Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C. M. A.
    van der Peet, Donald L.
    Bloemena, Elisabeth
    Mulder, Chris J. J.
    [J]. PANCREAS, 2010, 39 (08) : 1185 - 1190
  • [20] Perspectives on tomato disease resistance breeding: Past, present, and future
    Scott, JW
    [J]. Proceedings of the 1st International Symposium on Tomato Diseases, 2005, (695): : 217 - 224